TELA Bio Statistics
Total Valuation
TELA Bio has a market cap or net worth of $136.34 million. The enterprise value is $139.60 million.
Market Cap | 136.34M |
Enterprise Value | 139.60M |
Important Dates
The last earnings date was Thursday, May 9, 2024.
Earnings Date | May 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TELA Bio has 24.66 million shares outstanding. The number of shares has increased by 28.11% in one year.
Shares Outstanding | 24.66M |
Shares Change (YoY) | +28.11% |
Shares Change (QoQ) | +0.29% |
Owned by Insiders (%) | 2.27% |
Owned by Institutions (%) | 87.33% |
Float | 15.75M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.16 |
Forward PS | 1.69 |
PB Ratio | 9.48 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.21 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.13, with a Debt / Equity ratio of 2.83.
Current Ratio | 4.13 |
Quick Ratio | 3.12 |
Debt / Equity | 2.83 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -6.59 |
Financial Efficiency
Return on equity (ROE) is -155.30% and return on invested capital (ROIC) is -82.16%.
Return on Equity (ROE) | -155.30% |
Return on Assets (ROA) | -48.60% |
Return on Capital (ROIC) | -82.16% |
Revenue Per Employee | $278,181 |
Profits Per Employee | -$177,524 |
Employee Count | 227 |
Asset Turnover | 0.76 |
Inventory Turnover | 1.37 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.41% in the last 52 weeks. The beta is 1.00, so TELA Bio's price volatility has been similar to the market average.
Beta (1Y) | 1.00 |
52-Week Price Change | -45.41% |
50-Day Moving Average | 5.26 |
200-Day Moving Average | 6.39 |
Relative Strength Index (RSI) | 49.18 |
Average Volume (30 Days) | 159,857 |
Short Selling Information
The latest short interest is 1.15 million, so 4.64% of the outstanding shares have been sold short.
Short Interest | 1.15M |
Short Previous Month | 1.13M |
Short % of Shares Out | 4.64% |
Short % of Float | 7.27% |
Short Ratio (days to cover) | 5.00 |
Income Statement
In the last 12 months, TELA Bio had revenue of $63.15 million and -$40.30 million in losses. Loss per share was -$1.67.
Revenue | 63.15M |
Gross Profit | 43.55M |
Operating Income | -45.23M |
Pretax Income | -40.30M |
Net Income | -40.30M |
EBITDA | -34.16M |
EBIT | -34.99M |
Loss Per Share | -$1.67 |
Balance Sheet
The company has $37.41 million in cash and $40.67 million in debt, giving a net cash position of -$3.26 million or -$0.13 per share.
Cash & Cash Equivalents | 37.41M |
Total Debt | 40.67M |
Net Cash | -3.26M |
Net Cash Per Share | -$0.13 |
Equity / Book Value | 14.38M |
Book Value Per Share | 0.58 |
Working Capital | 47.44M |
Cash Flow
In the last 12 months, operating cash flow was -$43.67 million and capital expenditures -$788,000, giving a free cash flow of -$44.46 million.
Operating Cash Flow | -43.67M |
Capital Expenditures | -788,000 |
Free Cash Flow | -44.46M |
FCF Per Share | -$1.81 |
Margins
Gross margin is 68.97%, with operating and profit margins of -71.62% and -63.82%.
Gross Margin | 68.97% |
Operating Margin | -71.62% |
Pretax Margin | -63.82% |
Profit Margin | -63.82% |
EBITDA Margin | -54.10% |
EBIT Margin | -55.41% |
FCF Margin | -70.40% |
Dividends & Yields
TELA Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -28.11% |
Shareholder Yield | -28.11% |
Earnings Yield | -29.56% |
FCF Yield | -32.60% |
Analyst Forecast
The average price target for TELA Bio is $13.00, which is 135.08% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $13.00 |
Price Target Difference | 135.08% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 28.89% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TELA Bio has an Altman Z-Score of -4.88 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.88 |
Piotroski F-Score | 3 |